Relation between molecular configuration and certain biological actions of alpha-methyldopamine and alpha-methyl-meta-tyramine and their beta-hydroxylated products alpha-methylnorepinephrine and metaraminol.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D055598:Chemical Phenomena; D002621:Chemistry; D004298:Dopamine / Q000494:pharmacology*; D005260:Female; D006321:Heart / Q000187:drug effects; D008297:Male; D008680:Metaraminol / Q000494:pharmacology*; D051379:Mice; D009206:Myocardium / Q000378:metabolism*; D009647:Normetanephrine / Q000494:pharmacology*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012694:Serine / Q000494:pharmacology; D014439:Tyramine / Q000494:pharmacology*
D009647:Normetanephrine; D012694:Serine; D008680:Metaraminol; D012110:Reserpine; D004298:Dopamine; D014439:Tyramine